DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. DiscGenics is harnessing the restorative potential of cells native to the intervertebral disc to develop what we hope will be a profound therapeutic option for millions of patients suffering from the debilitating effects of back pain. DiscGenics’ first product candidate, IDCT, is a homologous, allogeneic, injectable cell therapy for the treatment of patients with mild to moderate degenerative disc disease.
View Top Employees from DiscGenicsWebsite | http://www.discgenics.com |
Revenue | $8 million |
Funding | $64.3 million |
Employees | 44 (44 on RocketReach) |
Founded | 2007 |
Address | 5940 W Harold Gatty Dr, Salt Lake City, Utah 84116, US |
Phone | (801) 410-0703 |
Technologies |
JavaScript,
HTML,
Twitter
+21 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Life Science, Therapeutics, Health Care |
Web Rank | 6 Million |
Keywords | Discgenics, Salt Lake City Biotech Companies, Disc Regeneration Stem Cell, Fda Drug Product Information Degeneratige Disc Disease, 1 In 4 Icon Png |
SIC | SIC Code 801 Companies, SIC Code 80 Companies |
NAICS | NAICS Code 62111 Companies, NAICS Code 621111 Companies, NAICS Code 621 Companies, NAICS Code 62 Companies, NAICS Code 6211 Companies |
Looking for a particular DiscGenics employee's phone or email?
The DiscGenics annual revenue was $8 million in 2024.
Flagg Flanagan is the Chief Executive Officer and Chairman of the Board of DiscGenics.
44 people are employed at DiscGenics.
DiscGenics is based in Salt Lake City, Utah.
The NAICS codes for DiscGenics are [62111, 621111, 621, 62, 6211].
The SIC codes for DiscGenics are [801, 80].